A strict regimen of monthly injections may not be necessary to counteract the effects of AMD, according to new research.
Researchers looking at 231 patients with the the neovascular, or ‘wet’, form of the condition found that they were able to reduce the number of injections a patient received over a three-and-a-half year period.
Using a Treat and Extend Regimen (TER) approach, they adapted the number of injections a patient received based on their response to the therapy. The number of intravitreal injections was reduced from one per month to an average of just over eight injections per year.
The research was presented at the annual meeting for the Association for Research in Vision and Ophthalmology (ARVO), in Orlando, Florida, earlier this week (May 5)